Can you provide the last earnings date for ADAPTIVE BIOTECHNOLOGIES?
ADAPTIVE BIOTECHNOLOGIES (ADPT) last reported earnings on 2/5/2026.
NASDAQ:ADPT • US00650F1093
Past quarterly earnings results for ADAPTIVE BIOTECHNOLOGIES (ADPT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.09 | -0.18 | 51.32% | 60.87% | 71.681M | 60.579M | 18.33% | 51.04% |
| Q3 2025 | 0.06 | -0.15 | 140.22% | 127.27% | 93.973M | 65.936M | 42.52% | 102.38% |
| Q2 2025 | -0.17 | -0.24 | 30.19% | 45.16% | 58.879M | 50.388M | 16.85% | 36.33% |
| Q1 2025 | -0.20 | -0.30 | 32.96% | 39.39% | 52.443M | 43.532M | 20.47% | 25.24% |
| Q4 2024 | -0.23 | -0.26 | 12.00% | 23.33% | 47.459M | 46.955M | 1.07% | 3.66% |
| Q3 2024 | -0.22 | -0.29 | 24.98% | 37.14% | 46.435M | 41.012M | 13.22% | 22.46% |
| Q2 2024 | -0.31 | -0.34 | 8.94% | 6.06% | 43.19M | 39.438M | 9.51% | -11.72% |
| Q1 2024 | -0.33 | -0.35 | 5.24% | 17.50% | 41.873M | 39.56M | 5.85% | 11.23% |
| Q4 2023 | -0.30 | -0.34 | 11.21% | -7.14% | 45.784M | 49.427M | -7.37% | -17.06% |
| Q3 2023 | -0.35 | -0.35 | -1.25% | -9.37% | 37.919M | 43.822M | -13.47% | -20.72% |
| Q2 2023 | -0.33 | -0.35 | 6.66% | 10.81% | 48.926M | 45.785M | 6.86% | 12.06% |
| Q1 2023 | -0.40 | -0.38 | -4.08% | 9.09% | 37.647M | 37.547M | 0.27% | -2.52% |
| Q4 2022 | -0.28 | -0.35 | 20.75% | 34.88% | 55.2M | 55.8M | -1.08% | 45.53% |
| Q3 2022 | -0.32 | -0.38 | 16.56% | 20.00% | 47.83M | 48.991M | -2.37% | 21.18% |
| Q2 2022 | -0.37 | -0.44 | 15.64% | -5.71% | 43.66M | 43.004M | 1.53% | 13.37% |
| Q1 2022 | -0.44 | -0.47 | 5.93% | -51.72% | 38.62M | 38.464M | 0.41% | 0.47% |
| Q4 2021 | -0.43 | -0.46 | 6.61% | -30.30% | 37.93M | 37.437M | 1.32% | 25.64% |
| Q3 2021 | -0.40 | -0.43 | 6.91% | -48.15% | 39.47M | 37.368M | 5.63% | 50.08% |
| Q2 2021 | -0.35 | -0.44 | 19.67% | -34.62% | 38.51M | 31.887M | 20.77% | 83.47% |
| Q1 2021 | -0.29 | -0.42 | 30.41% | -16.00% | 38.44M | 28.302M | 35.82% | 83.84% |
| Q4 2020 | -0.33 | -0.30 | -10.47% | - | 30.19M | 27.44M | 10.02% | - |
| Q3 2020 | -0.27 | -0.29 | 6.89% | - | 26.3M | 24.055M | 9.33% | - |
| Q2 2020 | -0.26 | -0.29 | 10.56% | - | 20.99M | 19.176M | 9.46% | - |
| Q1 2020 | -0.25 | -0.21 | -19.85% | - | 20.91M | 21.958M | -4.77% | - |
Notes
ADAPTIVE BIOTECHNOLOGIES (ADPT) last reported earnings on 2/5/2026.
ADAPTIVE BIOTECHNOLOGIES (ADPT) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, ADAPTIVE BIOTECHNOLOGIES (ADPT) has beaten EPS estimates in 4 out of 4 releases.